Sponsor Pipeline

Opus Genetics, Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
Active Trials by Phase
Phase 1/2
3
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT05616793 Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal… LCA5 Recruiting
NCT07185256 Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best… ARB Recruiting
NCT07681778 Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA-Associated Inherited… Leber Congenital Amaurosis Not Yet Recruiting
Get alerts when Opus Genetics, Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free